247 related articles for article (PubMed ID: 30573185)
1. Targeting NAD
Lewis JE; Singh N; Holmila RJ; Sumer BD; Williams NS; Furdui CM; Kemp ML; Boothman DA
Semin Radiat Oncol; 2019 Jan; 29(1):6-15. PubMed ID: 30573185
[TBL] [Abstract][Full Text] [Related]
2. Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.
Maier P; Hartmann L; Wenz F; Herskind C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784176
[TBL] [Abstract][Full Text] [Related]
3. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.
Ding M; Zhang E; He R; Wang X
Cancer Sci; 2013 Nov; 104(11):1401-10. PubMed ID: 23930697
[TBL] [Abstract][Full Text] [Related]
4. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes.
Kery M; Papandreou I
Br J Radiol; 2020 Nov; 93(1115):20200067. PubMed ID: 32462882
[TBL] [Abstract][Full Text] [Related]
5. NAD
Kennedy BE; Sharif T; Martell E; Dai C; Kim Y; Lee PW; Gujar SA
Pharmacol Res; 2016 Dec; 114():274-283. PubMed ID: 27816507
[TBL] [Abstract][Full Text] [Related]
6. NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study.
Zerp SF; Vens C; Floot B; Verheij M; van Triest B
Radiother Oncol; 2014 Feb; 110(2):348-54. PubMed ID: 24412016
[TBL] [Abstract][Full Text] [Related]
7. Novel radiosensitizing anticancer therapeutics.
Linkous AG; Yazlovitskaya EM
Anticancer Res; 2012 Jul; 32(7):2487-99. PubMed ID: 22753705
[TBL] [Abstract][Full Text] [Related]
8. Modulating the radiation response.
Coleman CN
Stem Cells; 1996 Jan; 14(1):10-5. PubMed ID: 8820945
[TBL] [Abstract][Full Text] [Related]
9. 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.
Coleman MC; Asbury CR; Daniels D; Du J; Aykin-Burns N; Smith BJ; Li L; Spitz DR; Cullen JJ
Free Radic Biol Med; 2008 Feb; 44(3):322-31. PubMed ID: 18215740
[TBL] [Abstract][Full Text] [Related]
10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
11. NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.
Di Stefano G; Manerba M; Vettraino M
Curr Top Med Chem; 2013; 13(23):2918-29. PubMed ID: 24171774
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
13. [Biomodulation and radiotherapy].
Bourhis J; Lartigau E
Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950
[TBL] [Abstract][Full Text] [Related]
14. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.
Gujar AD; Le S; Mao DD; Dadey DY; Turski A; Sasaki Y; Aum D; Luo J; Dahiya S; Yuan L; Rich KM; Milbrandt J; Hallahan DE; Yano H; Tran DD; Kim AH
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8247-E8256. PubMed ID: 27930300
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets for potentiation of radiation-induced cell killing.
Akimoto T
Breast Cancer; 2004; 11(2):121-8. PubMed ID: 15550856
[TBL] [Abstract][Full Text] [Related]
16. Pyridine Dinucleotides from Molecules to Man.
Fessel JP; Oldham WM
Antioxid Redox Signal; 2018 Jan; 28(3):180-212. PubMed ID: 28635300
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets in radiotherapy.
Brown JM
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):319-26. PubMed ID: 11173124
[TBL] [Abstract][Full Text] [Related]
18. Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlook.
Verheij M; Moolenaar WH; Blitterswijk WJ
Anticancer Agents Med Chem; 2014 May; 14(4):618-28. PubMed ID: 24628238
[TBL] [Abstract][Full Text] [Related]
19. NAD
Sultani G; Samsudeen AF; Osborne B; Turner N
J Neuroendocrinol; 2017 Oct; 29(10):. PubMed ID: 28718934
[TBL] [Abstract][Full Text] [Related]
20. The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.
Gallí M; Van Gool F; Rongvaux A; Andris F; Leo O
Cancer Res; 2010 Jan; 70(1):8-11. PubMed ID: 20028851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
